Cargando…

Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator

Detalles Bibliográficos
Autores principales: Valor-Méndez, Larissa, Dorn, Carla, Manger, Bernhard, Schett, Georg, Kleyer, Arnd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575662/
https://www.ncbi.nlm.nih.gov/pubmed/36268524
http://dx.doi.org/10.1093/rap/rkac079
_version_ 1784811358911463424
author Valor-Méndez, Larissa
Dorn, Carla
Manger, Bernhard
Schett, Georg
Kleyer, Arnd
author_facet Valor-Méndez, Larissa
Dorn, Carla
Manger, Bernhard
Schett, Georg
Kleyer, Arnd
author_sort Valor-Méndez, Larissa
collection PubMed
description
format Online
Article
Text
id pubmed-9575662
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95756622022-10-19 Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator Valor-Méndez, Larissa Dorn, Carla Manger, Bernhard Schett, Georg Kleyer, Arnd Rheumatol Adv Pract Letter to the Editor (Case report) Oxford University Press 2022-10-10 /pmc/articles/PMC9575662/ /pubmed/36268524 http://dx.doi.org/10.1093/rap/rkac079 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Letter to the Editor (Case report)
Valor-Méndez, Larissa
Dorn, Carla
Manger, Bernhard
Schett, Georg
Kleyer, Arnd
Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator
title Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator
title_full Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator
title_fullStr Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator
title_full_unstemmed Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator
title_short Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator
title_sort re-exposure with a tnf inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the tnf inhibitor bio-originator
topic Letter to the Editor (Case report)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575662/
https://www.ncbi.nlm.nih.gov/pubmed/36268524
http://dx.doi.org/10.1093/rap/rkac079
work_keys_str_mv AT valormendezlarissa reexposurewithatnfinhibitorbiosimilarwaswelltoleratedandledtosustainedcontrolofpsoriaticarthritisafterallergicreactiontothetnfinhibitorbiooriginator
AT dorncarla reexposurewithatnfinhibitorbiosimilarwaswelltoleratedandledtosustainedcontrolofpsoriaticarthritisafterallergicreactiontothetnfinhibitorbiooriginator
AT mangerbernhard reexposurewithatnfinhibitorbiosimilarwaswelltoleratedandledtosustainedcontrolofpsoriaticarthritisafterallergicreactiontothetnfinhibitorbiooriginator
AT schettgeorg reexposurewithatnfinhibitorbiosimilarwaswelltoleratedandledtosustainedcontrolofpsoriaticarthritisafterallergicreactiontothetnfinhibitorbiooriginator
AT kleyerarnd reexposurewithatnfinhibitorbiosimilarwaswelltoleratedandledtosustainedcontrolofpsoriaticarthritisafterallergicreactiontothetnfinhibitorbiooriginator